Responses
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1041 Discovery of a potential first-in-class small molecule inhibitor of ADAR1 p150 which demonstrates strong anti-tumor efficacy in B16F10 syngeneic melanoma model
Compose a Response to This Article
Other responses
No responses have been published for this article.
